Evidence map›Paper›PMID 23763856›Full record

SynthesisBMC medical informatics and decision making2013

Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.

Shobha Phansalkar, Amrita Desai, Anish Choksi, Eileen Yoshida, John Doole, Melissa Czochanski, Alisha D Tucker, Blackford Middleton, Douglas Bell, David W Bates

Abstract readSystematic Review
In one paragraph

Synthesis in BMC medical informatics and decision making, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Alert fatigue measurement in clinical decision support: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions.Journal of the American Medical Informatics Association : JAMIA · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shobha PhansalkarPartners Healthcare Systems, Inc, Wellesley, MA 02481, USA. sphansalkar@partners.org
Amrita Desai
Anish Choksi
Eileen Yoshida
John Doole
Melissa Czochanski
Alisha D Tucker
Blackford Middleton
Douglas Bell
David W Bates

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh override rates for drug-drug interaction (DDI) alerts in electronic health records (EHRs) result in the potentially dangerous consequence of providers ignoring clinically significant alerts. Lack of uniformity of criteria for determining the severity or validity of these interactions often results in discrepancies in how these are evaluated. The purpose of this study was to identify a set of criteria for assessing DDIs that should be used for the generation of clinical decision support (CDS) alerts in EHRs.

methodsWe conducted a 20-year systematic literature review of MEDLINE and EMBASE to identify characteristics of high-priority DDIs. These criteria were validated by an expert panel consisting of medication knowledge base vendors, EHR vendors, in-house knowledge base developers from academic medical centers, and both federal and private agencies involved in the regulation of medication use.

resultsForty-four articles met the inclusion criteria for assessing characteristics of high-priority DDIs. The panel considered five criteria to be most important when assessing an interaction- Severity, Probability, Clinical Implications of the interaction, Patient characteristics, and the Evidence supporting the interaction. In addition, the panel identified barriers and considerations for being able to utilize these criteria in medication knowledge bases used by EHRs.

conclusionsA multi-dimensional approach is needed to understanding the importance of an interaction for inclusion in medication knowledge bases for the purpose of CDS alerting. The criteria identified in this study can serve as a first step towards a uniform approach in assessing which interactions are critical and warrant interruption of a provider's workflow.

Indexed as

Drug InteractionsAdverse Drug Reaction Reporting SystemsDecision Support Systems, ClinicalElectronic Health RecordsHumansKnowledge BasesMedical Order Entry SystemsReference StandardsReproducibility of Results

Identifiers

PMID23763856
PMCPMC3706355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.